|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.440 SEK | +0.43% |
|
-0.63% | -8.08% |
| 12-09 | Finserve Micro Cap Drops 3.16 Percent in November Amid Mean Reversion Trends | FW |
| 11-11 | Moberg Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
| Capitalization | 444M 49.25M 41.88M 38.82M 36.28M 67.63M 4.52B 71.68M 176M 2.14B 185M 181M 7.77B | P/E ratio 2025 * |
-18.9x | P/E ratio 2026 * | -18.9x |
|---|---|---|---|---|---|
| Enterprise value | 444M 49.25M 41.88M 38.82M 36.28M 67.63M 4.52B 71.68M 176M 2.14B 185M 181M 7.77B | EV / Sales 2025 * |
35.8x | EV / Sales 2026 * | 19.2x |
| Free-Float |
78.15% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Moberg Pharma AB
More recommendations
More press releases
| 1 day | +0.43% | ||
| 1 week | -0.63% | ||
| Current month | -8.08% | ||
| 1 month | -5.98% | ||
| 3 months | +15.40% | ||
| 6 months | +4.95% | ||
| Current year | -8.08% |
| 1 week | 9 |  | 9.84 |
| 1 month | 9 | | 10.5 |
| Current year | 9 | | 10.5 |
| 1 year | 6.52 | | 12.1 |
| 3 years | 6.15 | | 40.9 |
| 5 years | 6.15 | | 78.4 |
| 10 years | 6.15 | | 861 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anna Ljung
CEO | Chief Executive Officer | 46 | 2019-05-14 |
Mark Beveridge
DFI | Director of Finance/CFO | 48 | 2014-12-31 |
| Sales & Marketing | 64 | 2019-01-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Nikolaj Sørensen
BRD | Director/Board Member | 54 | 2020-12-31 |
| Chairman | 60 | 2025-05-21 | |
| Director/Board Member | 57 | 2025-05-21 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.43% | -0.63% | -1.15% | -66.64% | 49.25M | |
| -2.12% | +2.49% | +35.51% | +207.25% | 953B | |
| +0.76% | +0.68% | +49.94% | +30.79% | 530B | |
| +0.53% | +2.29% | +28.75% | +48.46% | 388B | |
| +0.06% | -0.23% | +26.63% | +17.84% | 377B | |
| +0.15% | -3.36% | +22.90% | +26.80% | 286B | |
| +0.47% | +0.03% | +28.12% | +35.95% | 281B | |
| +1.17% | +3.20% | -35.52% | -16.14% | 281B | |
| -0.92% | -0.60% | +13.22% | -0.31% | 269B | |
| -0.67% | +4.34% | +25.17% | +32.75% | 186B | |
| Average | -0.01% | +0.60% | +19.36% | +31.67% | 355.05B | |
| Weighted average by Cap. | -0.35% | +0.91% | +26.54% | +72.83% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 12.4M 1.38M 1.17M 1.09M 1.01M 1.89M 126M 2M 4.92M 59.7M 5.16M 5.06M 217M | 23.1M 2.56M 2.18M 2.02M 1.89M 3.52M 236M 3.73M 9.17M 111M 9.61M 9.42M 405M |
| Net income | -21.4M -2.38M -2.02M -1.87M -1.75M -3.26M -218M -3.46M -8.5M -103M -8.91M -8.72M -375M | -22M -2.44M -2.08M -1.93M -1.8M -3.35M -224M -3.55M -8.73M -106M -9.16M -8.97M -385M |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
6
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-23 | 9.440 kr | +0.43% | 31,099 |
| 26-01-22 | 9.400 kr | -0.95% | 99,039 |
| 26-01-21 | 9.490 kr | -0.11% | 112,847 |
| 26-01-20 | 9.500 kr | +2.32% | 48,105 |
| 26-01-19 | 9.285 kr | -2.26% | 70,256 |
Delayed Quote Nasdaq Stockholm, January 23, 2026 at 12:00 pm
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MOB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition